Zimmer Biomet
956 hedge funds and large institutions have $19.7B invested in Zimmer Biomet in 2022 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 290 increasing their positions, 357 reducing their positions, and 91 closing their positions.
16% more call options, than puts
Call options by funds: $63.5M | Put options by funds: $55M
4% less first-time investments, than exits
New positions opened: 87 | Existing positions closed: 91
1.51% less ownership
Funds ownership: 91.19% → 89.68% (-1.5%)
2% less funds holding
Funds holding: 977 → 956 (-21)
8% less funds holding in top 10
Funds holding in top 10: 13 → 12 (-1)
19% less repeat investments, than reductions
Existing positions increased: 290 | Existing positions reduced: 357
19% less capital invested
Capital invested by funds: $24.3B → $19.7B (-$4.59B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$365M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$126M |
| 3 |
Morgan Stanley
New York
|
+$109M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$102M |
| 5 |
Neuberger Berman Group
New York
|
+$61.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Nuance Investments
Kansas City,
Missouri
|
-$244M |
| 2 |
Nordea Investment Management
Stockholm,
Sweden
|
-$221M |
| 3 |
JP Morgan Chase
New York
|
-$196M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$96M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$55M |
ZBH Hedge Fund Activity: Q2 2022 in Review
956 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q2 2022, worth a combined $19.7B — down 19% from $24.3B a quarter earlier.
Sellers outnumbered buyers: 91 funds closed out of ZBH and 87 opened new positions — a net loss of 4 holders — while 357 trimmed existing stakes and 290 added.
The largest buyer was Dodge & Cox, adding an estimated $365M. The largest seller was Nuance Investments, cutting an estimated $244M.
- 956 institutional investors held Zimmer Biomet (ZBH) as of Q2 2022, down from 977 in Q1 2022.
- Funds reported $19.7B of Zimmer Biomet stock for Q2 2022, down 19% quarter-over-quarter.
- 87 funds opened new Zimmer Biomet positions in Q2 2022 and 91 closed out, a net change of -4 holders.
- The largest Zimmer Biomet buyer in Q2 2022 was Dodge & Cox, an estimated $365M added.
- The largest Zimmer Biomet seller in Q2 2022 was Nuance Investments, an estimated $244M sold.
Based on aggregated 13F filings for Q2 2022.